CAS 2305757-96-2

VII-31

CAS: 2305757-96-2

VII-31

Pureza: ≥95%

Peso molecular: 427.51g/mol

Ref: 54-BUP21671

VII-31

CAS: 2305757-96-2

VII-31 is an analog of a kinase inhibitor that has shown promising results in the treatment of cancer. It works by inhibiting specific kinases that are involved in cancer cell growth and proliferation. This powerful tumor inhibitor induces apoptosis, or programmed cell death, in cancer cells, leading to their destruction. VII-31 has been found to be effective against a variety of human and Chinese cancer cell lines, making it a potential candidate for use as an anticancer drug. This protein-based medicinal compound can be isolated from urine and is being studied extensively for its potential therapeutic benefits. With its potent anti-tumor properties, VII-31 represents a promising avenue for the development of new cancer treatments.

Fórmula: C₂₃H₂₅NO₅S

Pureza: Min. 95%

Peso molecular: 427.5 g/mol

Ref: 3D-FSD75796

VII-31

CAS: 2305757-96-2

VII-31 is an activator of the NEDDylation pathway, capable of inducing apoptosis in MCF-7, PC-3, and MGC-803 cells.

Fórmula: C₂₃H₂₅NO₅S

Cor e Forma: Solid

Peso molecular: 427.51

Ref: TM-T62334